| CAR-T cell therapy for acute lymphoblastic leukemia: transforming the treatment of relapsed and refractory disease KC Pehlivan, BB Duncan, DW Lee Current hematologic malignancy reports 13, 396-406, 2018 | 171 | 2018 |
| Val-boroPro accelerates T cell priming via modulation of dendritic cell trafficking resulting in complete regression of established murine tumors MP Walsh, B Duncan, S Larabee, A Krauss, JPE Davis, Y Cui, SY Kim, ... PloS one 8 (3), e58860, 2013 | 56 | 2013 |
| Applying a clinical lens to animal models of CAR-T cell therapies BB Duncan, CE Dunbar, K Ishii Molecular Therapy-Methods & Clinical Development 27, 17-31, 2022 | 35 | 2022 |
| Murine pre–B-cell ALL induces T-cell dysfunction not fully reversed by introduction of a chimeric antigen receptor H Qin, K Ishii, S Nguyen, PP Su, CR Burk, BH Kim, BB Duncan, S Tarun, ... Blood, The Journal of the American Society of Hematology 132 (18), 1899-1910, 2018 | 25 | 2018 |
| A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapy BB Duncan, SL Highfill, H Qin, N Bouchkouj, S Larabee, P Zhao, ... Journal of Immunotherapy 36 (8), 400-411, 2013 | 22 | 2013 |
| Graft-versus-host disease impairs vaccine responses through decreased CD4+ and CD8+ T cell proliferation and increased perforin-mediated CD8+ T cell apoptosis CM Capitini, NM Nasholm, BB Duncan, M Guimond, TJ Fry The Journal of Immunology 190 (3), 1351-1359, 2013 | 21 | 2013 |
| A pan inhibitor of DASH family enzymes induces immunogenic modulation and sensitizes murine and human carcinoma cells to antigen-specific cytotoxic T lymphocyte killing … RN Donahue, BB Duncan, TJ Fry, B Jones, WW Bachovchin, CP Kiritsy, ... Vaccine 32 (26), 3223-3231, 2014 | 18 | 2014 |
| Treatment of refractory Diamond-Blackfan anemia with eltrombopag BB Duncan, J Lotter, J Superata, ME Barranta, I Darden, S Venugopal, ... Blood 140 (Supplement 1), 5824-5825, 2022 | 5 | 2022 |
| Cell Priming via Modulation of Dendritic Cell Trafficking Resulting in Complete Regression of Established Murine Tumors MP Walsh, B Duncan, S Larabee, A Krauss, JPE Davis, Y Cui, SY Kim, ... PLoS ONE 8, e58860, 2013 | 5 | 2013 |
| CAR-T cell therapy for acute lymphoblastic leukemia: transforming the treatment of relapsed and refractory disease. Curr Hematol Malig Rep. 2018; 13 (5): 396–406 KC Pehlivan, BB Duncan, DW Lee | 4 | |
| Treatment of refractory/relapsed Diamond–Blackfan anaemia with eltrombopag BB Duncan, JL Lotter, J Superata, ME Barranta, T Machado, I Darden, ... British Journal of Haematology 204 (5), 2077-2085, 2024 | 1 | 2024 |
| Unresectable Metastatic Testicular Germ Cell Tumor With Low-grade Neuroglial Neoplasm, Stable After Radiation and Chemotherapy S Tabibi, S Kamanda, N Llosa, CA Pratilas, BB Duncan, RS Esteves, ... Applied Immunohistochemistry & Molecular Morphology 31 (1), 47-50, 2023 | | 2023 |
| Poster: CT-167 Using the Sodium Iodide Symporter to Visualize CAR-T Cell Trafficking BB Duncan, J Mirazee, C Chien, S Cordes, S Hong, N Sato, D Young, ... Clinical Lymphoma, Myeloma and Leukemia 22, S187, 2022 | | 2022 |
| CT-167 Using the Sodium Iodide Symporter to Visualize CAR-T Cell Trafficking BB Duncan, J Mirazee, C Chien, S Cordes, S Hong, N Sato, D Young, ... Clinical Lymphoma Myeloma and Leukemia 22, S437, 2022 | | 2022 |
| Graft versus host disease impairs vaccine responses via decreased CD4+ and CD8+ T cell proliferation and increased CD8+ T cell apoptosis through the perforin pathway (126.27) N Nasholm, B Duncan, C Capitini, T Fry The Journal of Immunology 188 (1_Supplement), 126.27-126.27, 2012 | | 2012 |
| Alloreactivity Directed Against the Widely Distributed HY Antigen Impairs Antitumor Immunity and Results in T-Cell Dysfunction JC Shand, CM Capitini, H Qin, N Nasholm, BB Duncan, TJ Fry Blood 118 (21), 2964, 2011 | | 2011 |
